Morning Headlines 11/11/24
Doximity (DOCS) Tops Q2 Earnings and Revenue Estimates
Clinician network and drug marketing operator Doximity reports Q2 results: revenue up 20%, adjusted EPS $0.30 versus $0.22, beating expectations for both and sending DOCS shares up 34% in valuing the company at $11 billion.
McKesson, Oracle competing for Veradigm
McKesson, Oracle, and private equity firm Thoma Bravo are reportedly competing to acquire health IT, data, and analytics company Veradigm in a deal expected to close by Thanksgiving.
Waystar Reports Third Quarter 2024 Results
Waystar reports Q3 results: revenue up 22%, adjusted EPS $0.14 versus –$0.09, beating expectations for both.
Leidos awarded Organ Procurement and Transplantation Network operations contract
HHS awards Leidos a $235 million contract to modernize the country’s Organ Procurement and Transplant Network (OPTN).
Weird that Google can acknowledge its crowdsourced medical advice was wrong, but escape penalties for doing it wantonly at scale.